Middle East

Turkey confirms 19,357 daily COVID-19 cases

Ankara [Turkey], December 6 (ANI/Xinhua): Turkey on Sunday reported 19,357 new COVID-19 cases, raising its total tally of infections to 8,901,117, according to its health ministry.

ANI Dec 06, 2021 03:17 IST googleads

Ankara [Turkey], December 6 (ANI/Xinhua): Turkey on Sunday reported 19,357 new COVID-19 cases, raising its total tally of infections to 8,901,117, according to its health ministry.
The death toll from the virus in Turkey rose by 185 to 77,830, while 24,278 more people recovered in the last 24 hours.
A total of 350,937 tests were conducted over the past day, the ministry said.
Turkey started mass COVID-19 vaccination on Jan. 14 after the authorities approved the emergency use of the Chinese Sinovac vaccine.
More than 56.37 million people have received their first doses of vaccines, while over 50.65 million had their second doses. Turkey has so far administered over 120.91 million doses including third booster jabs. (ANI/Xinhua)

Tags:

Turkey booster vaccine second dose health booster jab COVID-19

Get the App

India consistently supported Maldives in crisis: Mohamed Nasheed

2026-03-12T17:24:56.194121+00:00 IST

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Europe

Indian Rights Activist raises cadaver organ donation issue at UN

2026-03-12T14:23:46.827538+00:00 IST

Gobind Gurbani, speaking through video conference, drew attention to the growing gap between the number of patients requiring organ transplants and the limited availability of donated organs.

Asia

Policy delays leave Pakistan short of critical medicines

2026-03-12T09:29:30.117743+00:00 IST

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Middle East